CADL insider trading
Candel Therapeutics, Inc.
In the past 36 days, 1 insider sold $3.2M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Paul Peter Tak Chief Executive Officer |
$3.2M 280,245 sh @ $11.28 |
−71.2% | Pre-scheduled | Sep 10, 2026 Filed Sep 11, 2026 |